- Home
- GIGM vs CRIS Comparison
GIGM vs CRIS Comparison
Compare GIGM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIGM | CRIS |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 14.0M |
| IPO Year | 2002 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GIGM | CRIS |
|---|---|---|
| Price | $1.49 | $0.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 7.7K | ★ 227.2K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | N/A | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $1.29 | $0.46 |
| 52 Week High | $1.89 | $3.13 |
Technical Indicators
Market Signals| Indicator | GIGM | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 45.11 |
| Support Level | $1.43 | $0.48 |
| Resistance Level | $1.59 | $0.63 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 92.97 | 49.04 |
Price Performance
Historical ComparisonAbout GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. The only segment and principal business of the company is digital entertainment service business, that operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. The company operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown. The company generates majority revenue from Taiwan.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.